SKIN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
69.2M
-4.1%
72.1M
+11.1%
64.9M
-21.2%
82.4M
+16.6%
70.7M
Cost of Revenue
22.0M
-3.3%
22.8M
+11.3%
20.5M
-30.2%
29.3M
+17.2%
25.0M
Gross Profit
47.1M
-4.4%
49.3M
+11.0%
44.4M
-16.2%
53.0M
+16.2%
45.6M
Operating Expenses
42.2M
-7.9%
45.8M
-1.0%
46.2M
-12.6%
52.9M
+1.9%
51.9M
R&D
1.7M
+18.1%
1.4M
+27.7%
1.1M
-34.4%
1.7M
-1.0%
1.7M
SG&A
40.5M
-8.7%
44.4M
-1.7%
45.1M
-11.8%
51.2M
+2.0%
50.2M
Operating Income
5.0M
+39.4%
3.6M
+298.3%
-1801000
-1211.7%
162.0K
+102.6%
-6242000
EBITDA
10.2M
+15.9%
8.8M
+150.2%
3.5M
-35.9%
5.5M
+151.6%
2.2M
Net Income
-888000
+66.7%
-2669000
+59.7%
-6630000
+18.2%
-8104000
+26.5%
-11031000
EPS (Basic)
$-0.14
+65.0%
$-0.40
+60.0%
$-1.00
+21.3%
$-1.27
+27.0%
$-1.74
EPS (Diluted)
$-0.14
+65.0%
$-0.40
+60.0%
$-1.00
+6.5%
$-1.07
+38.5%
$-1.74
Shares (Diluted)
6.5M
+0.5%
6.5M
-1.4%
6.6M
-12.9%
7.5M
+18.9%
6.3M
SkinHealth Systems (SKIN) — Financials